MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s15010-026-02742-w

Медицинская библиотека · Infection · 2026

Peri-interventional antibiotic prophylaxis in endoscopic valve implantation for lung volume reduction in COPD patients: results from a German multicenter observational cohort.

Pappe Eva, Darvishi Hadis, Sgarbossa Thomas, Saccomano Jacopo, Darwiche Kaid, Andreas Stefan, Eisenmann Stephan, Schmidt Bernd, Gesierich Wolfgang, Dickgreber Nicolas, Geltner Christian, Ficker Joachim Hans, Holland Angelique, Schwick Björn, Eggeling Stephan, Eberhardt Ralf, Grah Christian, Hünermann Christoph, Sommerwerck Urte, Fertl Andreas, Kurz Sylke, Schramm Peter, von Schöning Dinah, Sander Leif Erik, Witzenrath Martin, Hübner Ralf-Harto, German Lung Emphysema Registry study group

СтатьяМногоцентровое исследованиеНаблюдательное исследованиеПеревод в очереди

Аннотация

BACKGROUND

Endoscopic lung volume reduction (ELVR) using endobronchial valves is an established treatment for advanced COPD and emphysema. To reduce procedure-related complications such as pneumonia or exacerbations, peri-interventional antibiotic prophylaxis is commonly used; however, its clinical benefit remains uncertain. We aimed to evaluate the effect of different peri-interventional antibiotic strategies in a German COPD cohort.

METHODS

Comparative analyses were performed using data from 900 patients enrolled in the multicentre, observational German Lung Emphysema Registry (LE-Registry). Patients were categorized by peri-interventional antibiotic strategy: single-dose prophylaxis, prolonged prophylaxis for 5-7 days, or no prophylaxis. Baseline characteristics, airway colonization, lung function, symptom burden, exercise capacity, and adverse events were assessed up to three months after ELVR.

RESULTS

Among 900 patients undergoing ELVR, 104 received single-dose prophylaxis, 344 prolonged 5-7-day prophylaxis, and 309 no antibiotic prophylaxis. Clinical improvements in lung function, symptom burden, and exercise capacity over three months were similar across all groups. Exacerbations occurred in 11.5% of patients receiving single-dose prophylaxis (12/104), 7.6% with prolonged prophylaxis (26/344), and 5.5% without prophylaxis (17/309; p = 0.12). Pneumonia was observed in 7.7% (8/104), 3.2% (11/344), and 3.2% (10/309), respectively (p = 0.087). Antibiotic-related adverse events were infrequent and mild, occurring only in the prolonged prophylaxis group.

CONCLUSION

Peri-interventional antibiotic prophylaxis, whether single-dose or prolonged, did not improve clinical outcomes or reduce complication rates following ELVR. These findings indicate limited clinical benefit and support a more targeted, indication-based use of antibiotics in this setting.

Для цитирования: Pappe Eva, Darvishi Hadis, Sgarbossa Thomas, Saccomano Jacopo, Darwiche Kaid, Andreas Stefan, Eisenmann Stephan, Schmidt Bernd, Gesierich Wolfgang, Dickgreber Nicolas, Geltner Christian, Ficker Joachim Hans, Holland Angelique, Schwick Björn, Eggeling Stephan, Eberhardt Ralf, Grah Christian, Hünermann Christoph, Sommerwerck Urte, Fertl Andreas, Kurz Sylke, Schramm Peter, von Schöning Dinah, Sander Leif Erik, Witzenrath Martin, Hübner Ralf-Harto, German Lung Emphysema Registry study group. Peri-interventional antibiotic prophylaxis in endoscopic valve implantation for lung volume reduction in COPD patients: results from a German multicenter observational cohort.. Infection. 2026. DOI: 10.1007/s15010-026-02742-w.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.